Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.
Comments